James Dudley Management

james-dudley.co.uk

Over the past 20 years James Dudley Management has gained a well-respected name in the European healthcare industry for knowledge based, strategic marketing consultancy and has acquired expertise in a number of key areas.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

DERMALIQ THERAPEUTICS SIGNS USD 15 MILLION SERIES A ROUND TO ADVANCE THREE TRANSFORMATIVE DRUG THERAPIES INTO CLINICAL TRIALS

Dermaliq Therapeutics | January 18, 2022

news image

Novaliq GmbH, 3E Bioventures Capital and Beijing Whale Technology Corporation Ltd. today announced the establishment of Dermaliq Therapeutics, Inc (Dermaliq), a newly formed Delaware-based pharmaceutical development company, and the signing of a USD 15 million Series A financing round. 3E Bioventures Capital, a leading international life science investor, led the round and was joined by Beijing Whale Technology Corporation Ltd. Dermaliq's existing shareholder Novaliq has transferred, and lic...

Read More

PHARMACY MARKET

RX-360 LAUNCHES NEW AUDITSPLUS®

Rx-360 | June 10, 2021

news image

Rx-360, a global pharmaceutical consortium committed to supply chain integrity and patient safety, is happy to announce the extension of our Audit Program. The release of the new Rx-360 auditsPlus database is the key driver of this growth. This interactive, user-friendly database will not only raise awareness of the Rx-360 Joint Audit Program®. Still, it will also provide Rx-360 program users with new and improved tools to minimize their audit burden. Rx-360's CEO, Jim Fri...

Read More

WEBINAR HOSTED BY XTALKS TO COVER ACTIONS PHARMACEUTICAL COMMERCIAL TEAMS CAN TAKE TO STAY ON TRACK WITH 2020 GOALS

Xtalks | July 08, 2020

news image

COVID-19 swiftly changed the healthcare landscape around the world. There has been no rulebook for pharmaceutical commercialization during COVID-19. Pharmaceutical commercialization teams have had to quickly adapt to meet customer, community and business needs. Remote customer engagement and increased patient support services were the answer in the short term for pharmaceutical commercialization amid COVID-19. Longer term, teams will need to adapt brand strategy and executional approaches for in...

Read More

BUSINESS INSIGHTS

SIMULATIONS PLUS COLLABORATES WITH MULTINATIONAL PHARMACEUTICAL COMPANY TO PROVIDE MODELING & SIMULATION SUPPORT FOR COVID-19 TREATMENT

Simulations Plus, Inc | June 24, 2022

news image

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its Cognigen division worked with a major pharmaceutical company to implement modeling and simulation activities to support the development of a candidate COVID-19 therapy. This modeling and simulation work provided significant contributions towards regulatory submissions for the compound. Early in the COVID-19 pandemic, the pharma...

Read More
news image

BUSINESS INSIGHTS

DERMALIQ THERAPEUTICS SIGNS USD 15 MILLION SERIES A ROUND TO ADVANCE THREE TRANSFORMATIVE DRUG THERAPIES INTO CLINICAL TRIALS

Dermaliq Therapeutics | January 18, 2022

Novaliq GmbH, 3E Bioventures Capital and Beijing Whale Technology Corporation Ltd. today announced the establishment of Dermaliq Therapeutics, Inc (Dermaliq), a newly formed Delaware-based pharmaceutical development company, and the signing of a USD 15 million Series A financing round. 3E Bioventures Capital, a leading international life science investor, led the round and was joined by Beijing Whale Technology Corporation Ltd. Dermaliq's existing shareholder Novaliq has transferred, and lic...

Read More
news image

PHARMACY MARKET

RX-360 LAUNCHES NEW AUDITSPLUS®

Rx-360 | June 10, 2021

Rx-360, a global pharmaceutical consortium committed to supply chain integrity and patient safety, is happy to announce the extension of our Audit Program. The release of the new Rx-360 auditsPlus database is the key driver of this growth. This interactive, user-friendly database will not only raise awareness of the Rx-360 Joint Audit Program®. Still, it will also provide Rx-360 program users with new and improved tools to minimize their audit burden. Rx-360's CEO, Jim Fri...

Read More
news image

WEBINAR HOSTED BY XTALKS TO COVER ACTIONS PHARMACEUTICAL COMMERCIAL TEAMS CAN TAKE TO STAY ON TRACK WITH 2020 GOALS

Xtalks | July 08, 2020

COVID-19 swiftly changed the healthcare landscape around the world. There has been no rulebook for pharmaceutical commercialization during COVID-19. Pharmaceutical commercialization teams have had to quickly adapt to meet customer, community and business needs. Remote customer engagement and increased patient support services were the answer in the short term for pharmaceutical commercialization amid COVID-19. Longer term, teams will need to adapt brand strategy and executional approaches for in...

Read More
news image

BUSINESS INSIGHTS

SIMULATIONS PLUS COLLABORATES WITH MULTINATIONAL PHARMACEUTICAL COMPANY TO PROVIDE MODELING & SIMULATION SUPPORT FOR COVID-19 TREATMENT

Simulations Plus, Inc | June 24, 2022

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its Cognigen division worked with a major pharmaceutical company to implement modeling and simulation activities to support the development of a candidate COVID-19 therapy. This modeling and simulation work provided significant contributions towards regulatory submissions for the compound. Early in the COVID-19 pandemic, the pharma...

Read More